Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
EMERGENT BIOTECHNOLOGIES LLC has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $610,680 between 2019 and 2022. These are non-dilutive federal research grants, not equity financing. The company is based in Temple, Texas.
2 rounds · latest SBIR Phase I award (HHS), Sep 2022
Sign in to see 2 rounds.
Sign inNo investors recorded yet for EMERGENT BIOTECHNOLOGIES LLC.
Add an investorEMERGENT BIOTECHNOLOGIES LLC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for EMERGENT BIOTECHNOLOGIES LLC.
Add diversity data